A LEXICOGRAPHIC MINIMAX ALGORITHM FOR MULTIPERIOD RESOURCE-ALLOCATION von KLEIN, RS, LUSS, H, SMITH, DR

Volltext

Multiperiod allocation of substitutable resources von Klein, Rachelle S., Luss, Hanan, Rothblum, Uriel G.

Volltext

Minimax Resource Allocation Problems with Resource-Substitutions Represented by Graphs von Klein, Rachelle S, Luss, Hanan, Rothblum, Uriel G

Volltext

Minimax Resource Allocation with Tree Structured Substitutable Resources von Klein, Rachelle S, Luss, Hanan

Volltext

Relaxation-based algorithms for minimax optimization problems with resource allocation applications von KLEIN, R. S, LUSS, H, ROTHBLUM, U. G

Volltext

Inventory Requirements Planning at Lucent Technologies von Bangash, Alex, Bollapragada, Ramesh, Klein, Rachelle, Raman, Narayan, Shulman, Herbert B, Smith, Donald R

Volltext

Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease von Bateman, Randall J., Smith, Janice, Donohue, Michael C., Delmar, Paul, Abbas, Rachid, Salloway, Stephen, Wojtowicz, Jakub, Blennow, Kaj, Bittner, Tobias, Black, Sandra E., Klein, Gregory, Boada, Mercè, Grimmer, Timo, Tamaoka, Akira, Perry, Richard J., Turner, R. Scott, Watson, David, Woodward, Michael, Thanasopoulou, Angeliki, Lane, Christopher, Baudler, Monika, Fox, Nick C., Cummings, Jeffrey L., Fontoura, Paulo, Doody, Rachelle S.

Volltext

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease von Bateman, Randall J, Cummings, Jeffrey, Schobel, Scott, Salloway, Stephen, Vellas, Bruno, Boada, Mercè, Black, Sandra E, Blennow, Kaj, Fontoura, Paulo, Klein, Gregory, Assunção, Sheila Seleri, Smith, Janice, Doody, Rachelle S

Volltext

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis von Klein, Gregory, Delmar, Paul, Voyle, Nicola, Rehal, Sunita, Hofmann, Carsten, Abi-Saab, Danielle, Andjelkovic, Mirjana, Ristic, Smiljana, Wang, Guoqiao, Bateman, Randall, Kerchner, Geoffrey A, Baudler, Monika, Fontoura, Paulo, Doody, Rachelle

Volltext

Structural resolution and mechanistic insight into hydrogen adsorption in flexible ZIF-7 von Klein, Ryan A, Shulda, Sarah, Parilla, Philip A, Le Magueres, Pierre, Richardson, Rachelle K, Morris, William, Brown, Craig M, McGuirk, C. Michael

Volltext

Development of a quantitative semi‐mechanistic model of Alzheimer's disease based on the amyloid/tau/neurodegeneration framework (the Q‐ATN model) von Mazer, Norman A., Hofmann, Carsten, Lott, Dominik, Gieschke, Ronald, Klein, Gregory, Boess, Frank, Grimm, Hans Peter, Kerchner, Geoffrey A., Baudler‐Klein, Monika, Smith, Janice, Doody, Rachelle S.

Volltext

MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer von Dammert, Marcel A., Brägelmann, Johannes, Olsen, Rachelle R., Böhm, Stefanie, Monhasery, Niloufar, Whitney, Christopher P., Chalishazar, Milind D., Tumbrink, Hannah L., Guthrie, Matthew R., Klein, Sebastian, Ireland, Abbie S., Ryan, Jeremy, Schmitt, Anna, Marx, Annika, Ozretić, Luka, Castiglione, Roberta, Lorenz, Carina, Jachimowicz, Ron D., Wolf, Elmar, Thomas, Roman K., Poirier, John T., Büttner, Reinhard, Sen, Triparna, Byers, Lauren A., Reinhardt, H. Christian, Letai, Anthony, Oliver, Trudy G., Sos, Martin L.

Volltext

Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes von Hayward, Rodney A, Reaven, Peter D, Wiitala, Wyndy L, Bahn, Gideon D, Reda, Domenic J, Ge, Ling, McCarren, Madeline, Duckworth, William C, Emanuele, Nicholas V

Volltext

Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up von Reaven, Peter D, Emanuele, Nicholas V, Wiitala, Wyndy L, Bahn, Gideon D, Reda, Domenic J, McCarren, Madeline, Duckworth, William C, Hayward, Rodney A

Volltext

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease von Salloway, Stephen, Wojtowicz, Jakub, Voyle, Nicola, Lane, Christopher A, Klein, Gregory, Lyons, Marco, Rossomanno, Simona, Mazzo, Francesca, Bullain, Szofia, Barkhof, Frederik, Bittner, Tobias, Schneider, Andres, Grundman, Michael, Aldea, Roxana, Boada, Mercè, Smith, Janice, Doody, Rachelle

Volltext

Using an external control to contextualize efficacy data from patients with prodromal and mild Alzheimer’s disease treated with gantenerumab in SCarlet RoAD and Marguerite RoAD ope... von Delmar, Paul, Huang, Zhiyue, Neve, Anuja, Klein, Gregory, Kerchner, Geoffrey A., Fontoura, Paulo, Baudler, Monika, Doody, Rachelle S.

Volltext

Baseline Characteristics of the GRADUATE Studies: Phase III Randomized, Placebo-Controlled Studies Investigating Subcutaneous Gantenerumab in Participants with Early Alzheimer’s Di... von Lane, Christopher, Bullain, Szofia, Thanasopoulou, Angeliki, Delmar, Paul, Boada, Mercè, Grimmer, Timo, Kerwin, Diana, Fontoura, Paulo, Baudler-Klein, Monika, Kerchner, Geoffrey A., Doody, Rachelle S.

Volltext

PostGraduate Open-label Rollover Study: Evaluation of Subcutaneous Gantenerumab Long-term Safety, Tolerability, and Efficacy in Participants with Alzheimer’s Disease (P6-3.002) von Lane, Christopher, Thanasopoulou, Angeliki, Delmar, Paul, Searle, Alison, Mazzo, Francesca, Ehrhard, Patricia, Fontoura, Paulo, Baudler-Klein, Monika, Kerchner, Geoffrey A., Doody, Rachelle S.

Volltext

Re‐estimation of drug‐specific amyloid removal parameters and the rate constant for pathogenic tau turnover brings the Q‐ATN model into better alignment with recent phase 3 data fr... von Mazer, Norman A, Lott, Dominik, Grimm, Hans Peter, Machacek, Matthias, Boess, Frank, Gieschke, Ronald, Klein, Gregory, Baudler, Monika, Doody, Rachelle S.

Volltext

GRADUATE I and II: Subgroup analysis and correlations of biomarkers von Bittner, Tobias, Belousov, Anton, Lane, Christopher, Schwab, Dietmar, Klein, Gregory, Tonietto, Matteo, Lott, Dominik, Illiano, Vittorio P, Blennow, Kaj, Barkhof, Frederik, Smith, Janice, Doody, Rachelle S.

Volltext